NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/21/2023
Back to search
Official data from USPTO
MEDILINKTHERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
9
Latest update
02/21/2023
Trademark type
Combined
Nice classes
5
Filing date
03/14/2022
Registration date
02/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/21/2023
Last transaction
02/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
Suzhou, Jiangsu, CN
Examiner
KRUSSMAN, IAN
Law office
T60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "MEDILINKTHERA".
Holders and representatives
Holders
MediLink Therapeutics(Suzhou)Co.,Ltd.
Representatives
TIMOTHY T. WANG NI, WANG & MASSAND, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Disinfectants; Pesticides; Anti-infective products for veterinary use; Cotton for medical purposes; Dental lacquer; Depuratives for the body; Disinfectant wipes; Gases and gas mixtures for medical imaging use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemiacancercardiovascular system diseasescentral nervous system diseasesperipheral nervous system diseasescirculatory system diseasesdigestive system diseasesautoimmune diseasesbacteria-based diseases and infectious diseases; Nutritional food additives for medical purposes in the nature of natural food extracts derived from fishmeat and vegetables; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritive substances for microorganisms for medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention of anemiacancercardiovascular system diseasescentral nervous system diseasesperipheral nervous system diseasescirculatory system diseasesdigestive system diseasesautoimmune diseasesbacteria-based diseases and infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparationselixirs for the treatment of anemiacancercardiovascular system diseasescentral nervous system diseasesperipheral nervous system diseasescirculatory system diseasesdigestive system diseasesautoimmune diseasesbacteria-based diseases and infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Sugar replacement for medicinal or therapeutic purposes; Therapeutic pharmaceutical for the treatment of anemiacancercardiovascular system diseasescentral nervous system diseasesperipheral nervous system diseasescirculatory system diseasesdigestive system diseasesautoimmune diseasesbacteria-based diseases and infectious diseases; Veterinary preparationspain relief medication
Publications
History of USPTO decisions and trademark events.
9 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/06/2022
PUBO
PUBLISHED FOR OPPOSITION
12/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2022
DOCK
ASSIGNED TO EXAMINER
10/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2022
NWAP
NEW APPLICATION ENTERED
03/17/2022
Continuous trademark protection
Get notified about every new filing that threatens MEDILINKTHERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.